CORT vs PG · P/E 199, rev $675.0M vs P/E 25, rev $84.28B
Corcept Therapeutics Incorporated (CORT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CORT and PG stock pages for the full models.
Not investment advice.